Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction | Transaction Date | Filing Date | Details |
---|---|---|---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P.other: Former 10% Owner |
Buy | 5,714,285 @ $0.00 | $5,714 | 5,714,285 | 05/10/2024 | 05/14/2024 | |
Gall MatthewCFO |
Buy | 5,000 @ $8.37 | $41,850 | 19,429 | 10/12/2023 | 10/12/2023 | |
Boxer Capital, LLC |
Sell | 34,846 @ $14.19 | $494,465 | 2,119,212 | 08/23/2023 | 08/25/2023 | |
Boxer Capital, LLC |
Sell | 95,516 @ $15.63 | $1.49 M | 2,023,696 | 08/23/2023 | 08/25/2023 | |
Boxer Capital, LLC |
Sell | 219,638 @ $16.87 | $3.71 M | 1,804,058 | 08/23/2023 | 08/25/2023 |
Member of congress | Current Price | Type | Trade Data | Date Filed | Date Traded |
---|
A. The list of insiders at iTeos Therapeutics, Inc. includes Boxer Capital, LLC, Gall Matthew, RA CAPITAL MANAGEMENT, L.P..
A. Insiders have sold a total of 350,000 iTeos Therapeutics, Inc. shares in the last 12 months for a total of 5.69 M sold.
A. The following insiders have sold iTeos Therapeutics, Inc. shares in the last 12 months: Boxer Capital, LLC ($5.69 M),
A. Insiders have purchased a total of 5.72 M iTeos Therapeutics, Inc. shares in the last 12 months for a total of 47,564 sold.
A. The following insiders have purchased iTeos Therapeutics, Inc. shares in the last 12 months: Gall Matthew ($41,850), RA CAPITAL MANAGEMENT, L.P. ($5,714),